Katalog der Deutschen Nationalbibliothek

Go to:

Knowledge Web

Person
Person

Person

Klaus Hans Metzeler (1978-)

Name

Klaus Hans Metzeler

Time

1978- (Date of birth and death)

Place

Memmingen (Geburtsort)
Deutschland

Variant

Klaus Metzeler (Metadaten)

Further information

Diss. Medizinische Fakultät an der Ludwig-Maximilians-Universität München

Source

AM Metadaten

Record type

Person

GND-Identifier

130630810

Record ID

130630810

Involved in

show all

Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia

Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia – a HARMONY study

Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation

Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients

Quality of life and life satisfaction in long-term survivors of acute myeloid leukemia

Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessment

Sex-associated differences in outcome of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation

Thiamine-Responsive Megaloblastic Anemia Syndrome Mimicking Myelodysplastic Neoplasm

Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles

Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche

Prognostic impact of CEBPA mutational subgroups in adult AML

Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma

DNMT3A mutations in chronic myeloid leukemia

Einfluss von ASXL1-Mutationen auf das Therapieansprechen bei Patienten mit chronischer myeloischer Leukämie

Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation

Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles

Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy

Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation

Clonal hematopoiesis and cardiovascular disease: deciphering interconnections

Compartment-specific mutational landscape of clonal hematopoiesis

Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms – results of the EUROPE trial by EMSCO

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study

rhG-CSF plus Decitabin verhindert Rückfall bei Hochrisiko-AML nach erfolgreicher allo-HSCT

Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia

Präzisionsonkologie und molekulare Tumorboards – Konzepte, Chancen und Herausforderungen

Präzisionsonkologie und molekulare Tumorboards – Konzepte, Chancen und Herausforderungen

Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis

Genetik der akuten myeloischen Leukämie : Bedeutung für Pathogenese, Prognose und Therapie

Molecular genetic characterization of individual cancer cells isolated via single-cell printing

Ein lokales GABAerges System in der Nebennierenrinde des Menschen und der Ratte

Ein lokales GABAerges System in der Nebennierenrinde des Menschen und der Ratte
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal